Eugenol restrains abdominal aortic aneurysm progression with down‐regulations on NF‐κB and COX‐2
Sign Up to like & getrecommendations! Published in 2022 at "Phytotherapy Research"
DOI: 10.1002/ptr.7358
Abstract: Abdominal aortic aneurysm (AAA) is a lethal disease without available medicine for treatment. This study aimed to evaluate the efficiency of eugenol (4‐allyl‐2‐methoxyphenol) against AAA and the underlying mechanism. Eugenol is the major bioactive component… read more here.
Keywords: aaa progression; progression; abdominal aortic; aortic aneurysm ... See more keywords
Flow‐Mediated Dilatation as a Biomarker of AAA Progression: FT06.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Vascular Surgery"
DOI: 10.1016/j.jvs.2017.03.032
Abstract: an overall in-hospital mortality of 7.2% (7 of 97). Follow-up data were obtained from all patients, and the mean follow-up time was 43.36 25.5 months. The 5-year survival rate by Kaplan-Meier analysis was 86. 6%.… read more here.
Keywords: mediated dilatation; biomarker aaa; aaa progression; dilatation biomarker ... See more keywords
Soluble ST2 as a Potential Biomarker for Abdominal Aortic Aneurysms—A Single-Center Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23179598
Abstract: The maximal aortic diameter is the only clinically applied predictor of abdominal aortic aneurysm (AAA) progression and indicator for surgical repair. Circulating biomarkers resulting from AAA pathogenesis are attractive candidates for the diagnosis and prognosis… read more here.
Keywords: aaa progression; single center; aaa patients; abdominal aortic ... See more keywords